Trial
NCT02187848
Evaluation of SAR408701 in Patients With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Neoplasm Malignant
Intervention
SAR408701
Why stopped
Sponsor decision, The decision is not related to any safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-10